Refine
Has Fulltext
- yes (23)
Is part of the Bibliography
- yes (23)
Year of publication
Document Type
- Journal article (18)
- Doctoral Thesis (5)
Keywords
- chronic kidney disease (3)
- coronary heart disease (3)
- cardiac surgery (2)
- guideline adherence (2)
- AKI (1)
- Akutes Nierenversagen (1)
- Angiotensin II (1)
- Arteriosklerose (1)
- CD137-Antigen (1)
- COMT (1)
- Cardiovascular risk factors (1)
- Cardiovascular risk prediction (1)
- Carotid intima-media thickness (CIMT) (1)
- Carotid segment (1)
- Carotid ultrasound (1)
- Chronic kidney disease (1)
- Chronische Nierenerkrankung (1)
- EUROASPIRE survey (1)
- Elektronenmikroskopie (1)
- Fabry disease (1)
- Genotoxizität (1)
- Glomerulosklerose (1)
- Herzthoraxchirurgie (1)
- ICD-coding of CKD (1)
- KDIGO (1)
- Karl Leonhard (1)
- Kolonkarzinom (1)
- Kostimulatorische Signalwege (1)
- LDL (1)
- Nanopartikel (1)
- PD-1-Antigen (1)
- Pannexin (1)
- Proliferation (1)
- Quality of life (1)
- Repetitive Exposition (1)
- SF-36 (1)
- Schizophrenie (1)
- Sekundärprävention (1)
- Signaltransduktion (1)
- ZnO (1)
- Zytotoxizität (1)
- acute kidney injury (1)
- anemia (1)
- angiotensin II (1)
- anxiety (1)
- arterial stiffening (1)
- arteriosclerosis (1)
- atherosclerosis (1)
- awareness (1)
- calcification (1)
- cardiopulmonary bypass (1)
- cardiovascular risk factors (1)
- carotid artery disease (1)
- colonoscopy (1)
- coronary artery disease (1)
- cytotoxicity (1)
- diabetes mellitus (1)
- endovascular treatment (1)
- euroaspire (1)
- ferritin (1)
- genotoxicity (1)
- giant intracranial aneurysm (1)
- glomerulosclerosis (1)
- guideline implementation (1)
- heart failure (1)
- heme oxygenase-1 (1)
- hemoglobin (1)
- human skin (1)
- humane mesenchymale Stammzellen (1)
- hypertension (1)
- inflammation (1)
- koronare Herzerkrankung (1)
- left ventricular performance (1)
- mineralocorticoid antagonist (1)
- music (1)
- myocardial work (1)
- nanoparticle (1)
- nanoparticles (1)
- nanotoxicology (1)
- panx1 (1)
- panx2 (1)
- panx3 (1)
- pathogenicity (1)
- patients’ awareness (1)
- pharmacotherapy (1)
- physicians’ awareness (1)
- population-based study (1)
- postoperativ (1)
- preserved ejection fraction (1)
- prevalence (1)
- primary prevention (1)
- proliferation (1)
- prolonged survival (1)
- proteinuria (1)
- relaxation (1)
- risk factor control (1)
- schizophrenia (1)
- secondary prevention (1)
- stem cells (1)
- stress level (1)
- surgical aneurysm treatment (1)
- toxicity (1)
- type 2 diabetes (1)
- whole-genome analysis (1)
- zinc oxid (1)
- zinc oxide (1)
Institute
- Institut für Klinische Epidemiologie und Biometrie (14)
- Medizinische Klinik und Poliklinik I (12)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (8)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (6)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Graduate School of Life Sciences (1)
- Institut für Informatik (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Medizinische Klinik (bis 2004) (1)
- Medizinische Klinik und Poliklinik II (1)
Chronic Kidney Disease as an Important Co-morbid Condition in Coronary Heart Disease Patients
(2019)
In patients with coronary heart disease (CHD) the control of the modifiable “traditional” cardiovascular risk factors such as hypertension, dyslipidemia, diabetes, achieving/maintaining normal body weight and smoking cessation is of major importance to improve prognosis. Guideline recommendations for secondary CHD prevention include specific treatment targets for blood pressure, lipid levels, and markers of glucose metabolism for both younger and older patients. Chronic kidney disease (CKD) has been identified as a “non-traditional” risk factor for worse outcome in CHD patients, as it is associated with a markedly increased risk for subsequent CV events and mortality.
The specific objectives of the current thesis-project are to investigate (a) the quality of care in a recent sample of German CHD patients and to investigate variation of risk factor control between younger and elder patients (≤70 versus >70 years), (b) to analyze the prevalence of CKD across Europe in stable CHD patients in the outpatient setting and during a hospital stay for CHD, (c) to investigate the level of awareness of CKD in German CHD patients and their treating physicians.
Data from the European-wide EUROASPIRE IV study were used that include data on 7998 CHD patients in the ambulatory setting (study visit) and during a hospital stay for CHD (index). The German EUROASPIRE IV study center in Würzburg recruited 536 patients in 2012-2013. Risk factor control was compared against the current recommendations of the European Society of Cardiology. CKD was described by stages of glomerular filtration rate (eGFR) and albuminuria. German patients were asked in an additional kidney specific module whether they have ever been told by a physician about renal impairment. The fact that CKD or acute kidney injury (AKI) was mentioned in prominent parts of the hospital discharge letter as well as correct ICD-coding of CKD or AKI served as a proxy for physician’s awareness of CKD.
The majority of German CHD patients was treated with the recommended drug therapies including e.g. β-blockers, anti-platelets and statins. However, treatment targets for blood pressure and LDL-cholesterol levels were not achieved in many patients (45% and 53%, respectively) and glycemic control in diabetic CHD patients with HbA1-levels <7% was insufficient (61%). A minority of patients reported on current smoking (10%), but unhealthy life-styles e.g. overweight/obesity (85%/37%) were frequent. Patterns of care differed between younger and older CHD patients while older patients were less likely to receive the recommended medical CHD-therapy, were more likely to have uncontrolled blood pressure and also to be diabetic. However, a greater proportion of diabetic patients >70 years was achieving the HbA1c target, and less elder patients were current smokers or were obese. About 17% of patients on average had CKD (eGFR< 60 ml/min/1.73m²) in the entire European sample at the study visit, and an additional 10% had albuminuria despite preserved eGFR, with considerable variation among countries. Impaired kidney function was observed in every fifth patient admitted for CHD in the entire European dataset of the EUROASPIRE IV study. Of the German CHD patients with CKD at the study visit, only a third were aware of their renal impairment. A minority of these patients was being seen by nephrologists, however, with a higher likelihood of CKD awareness and specialist care in more advanced stages of CKD. About a third of patients admitted for CHD showed either CKD or AKI during the hospital stay, but the discharge letter mentioned chronic or acute kidney disease only in every fifth of these patients. In contrast, correct ICD coding of CKD or AKI was more complete, but still suboptimal.
In summary, quality of secondary prevention in German CHD patients indicates considerably room for improvement, with life-style modifications may become an even greater factor in prevention campaigns than medical treatment into certain target ranges. Preventive therapies should also consider different needs in older individuals acknowledging physical and mental potential, other comorbidities and drug-interactions with co-medication. CKD is common in CHD patients, not only in the elderly. Since CHD and CKD affect each other and impact on worse prognosis of each other, raising the awareness of CKD among patients and physicians and considering CKD in medical therapy may improve prognosis and slow disease progression of CHD as well as CKD.
Background
Chronic hyperglycemia (CHG) with HbA1c as an indicator affects postoperative mortality and morbidity after coronary artery bypass grafting surgery (CABG). Acute kidney injury (AKI) is one of the frequent postoperative complications after CABG impacting short-and long-term outcomes. We investigated the association between CHG and postoperative incidence of AKI in CABG patients with and without history of diabetes mellitus (DM).
Methods
This cohort study consecutively enrolled patients undergoing CABG in 2009 at the department for cardiovascular surgery. CHG was defined as HbA1c ≥ 6.0 %. Patients with advanced chronic kidney disease (CKD) were excluded. The incidence of postoperative AKI and its association with CHG was analyzed by univariate and multivariate logistic regression modeling.
Results
Three-hundred-seven patients were analyzed. The incidence of AKI was 48.2 %. Patients with CHG (n = 165) were more likely to be female and had greater waist circumference as well as other comorbid conditions, such as smoking, history of DM, CKD, hypertension, pulmonary hypertension, and chronic obstructive pulmonary disease (all p ≤ 0.05). Preoperative eGFR, atrial fibrillation (AF), history of DM and CHG were associated with an increased risk of postoperative AKI in univariate analyses. In multivariate modelling, history of DM as well as preoperative eGFR and AF lost significance, while age, CHG and prolonged OP duration (p < 0.05) were independently associated with postoperative AKI.
Conclusions
Our results suggest that CHG defined on a single measurement of HbA1c ≥ 6.0 % was associated with the incidence of AKI after CABG. This finding might implicate that treatment decisions, including the selection of operative strategies, could be based on HbA1c measurement rather than on a recorded history of diabetes.
Bestimmung von genetischen Veränderungen auf PANX 1-3 anhand von Einzelnukleotid Polymorphismen (SNP). Test auf Assoziation von Allelen und Haplotypen mit den schizophrenen Psychosen nach ICD-10 und der Klassifikation von Karl Leonhard in Form einer Fall-Kontroll-Studie mit 1163 Patienten und 479 Kontrollen.